{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:46:59Z","timestamp":1782474419105,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei Key Laboratory Open Project-Seed Fund Project","award":["2024KFZ028"],"award-info":[{"award-number":["2024KFZ028"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82502449"],"award-info":[{"award-number":["82502449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Province Key Research and Development Project","award":["2020BCB051"],"award-info":[{"award-number":["2020BCB051"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2042025YXB009"],"award-info":[{"award-number":["2042025YXB009"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Province Central Guiding Local Science and Technology Development Project","award":["2022BGE232"],"award-info":[{"award-number":["2022BGE232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01443-9","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:26:01Z","timestamp":1779189961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of artificial intelligence-based model for bladder cancer immunophenotyping using whole slide images"],"prefix":"10.1038","volume":"10","author":[{"given":"Qingyuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-3678","authenticated-orcid":false,"given":"Zhiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1443_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber, I. et al. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur. Urol. 84, 176\u2013190 (2023).","journal-title":"Eur. Urol."},{"key":"1443_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/CEJ.0000000000000364","volume":"27","author":"J Stojanovic","year":"2018","unstructured":"Stojanovic, J., Milovanovic, S., Pastorino, R., Iavicoli, I. & Boccia, S. Occupational exposures and genetic susceptibility to urinary tract cancers: a systematic review and meta-analysis. Eur. J. Cancer Prev. 27, 468\u2013476 (2018).","journal-title":"Eur. J. Cancer Prev."},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00345-018-2206-x","volume":"36","author":"S Akhtar","year":"2018","unstructured":"Akhtar, S., Al-Shammari, A. & Al-Abkal, J. Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies. World J. Urol. 36, 839\u2013848 (2018).","journal-title":"World J. Urol."},{"key":"1443_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.eururo.2023.04.020","volume":"84","author":"S Koutros","year":"2023","unstructured":"Koutros, S. et al. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur. Urol. 84, 127\u2013137 (2023).","journal-title":"Eur. Urol."},{"key":"1443_CR6","doi-asserted-by":"crossref","unstructured":"Alouini, S. Risk factors associated with urothelial bladder cancer. Int. J. Environ. Res. Public Health. 21, 954 (2024).","DOI":"10.3390\/ijerph21070954"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes, J. et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur. Urol. 85, 17\u201331 (2024).","journal-title":"Eur. Urol."},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccell.2021.04.012","volume":"39","author":"M Knowles","year":"2021","unstructured":"Knowles, M., Dyrskj\u00f8t, L., Heath, E. I., Bellmunt, J. & Siefker-Radtke, A. O. Metastatic urothelial carcinoma. Cancer Cell 39, 583\u2013585 (2021).","journal-title":"Cancer Cell"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat, E. et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet 400, 1712\u20131721 (2022).","journal-title":"Lancet"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","volume":"391","author":"T Powles","year":"2024","unstructured":"Powles, T. et al. Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. N. Engl. J. Med. 391, 1773\u20131786 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00432-023-05584-3","volume":"150","author":"G Huang","year":"2024","unstructured":"Huang, G., Xiong, H., Li, S., Zhu, Y. & Liu, H. The efficacy of immune checkpoint inhibitors therapy versus chemotherapy in the treatment of advanced and metastatic urothelial carcinoma: a meta-analysis. J. Cancer Res. Clin. Oncol. 150, 5 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1443_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104980","volume":"216","author":"EO Oisakede","year":"2025","unstructured":"Oisakede, E. O. et al. Predictive models for immune checkpoint inhibitor response in cancer: a review of current approaches and future directions. Crit. Rev. Oncol. Hematol. 216, 104980 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.annonc.2025.05.536","volume":"36","author":"TB Powles","year":"2025","unstructured":"Powles, T. B. et al. Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302\/KEYNOTE-A39 trial. Ann. Oncol. 36, 1212\u20131219 (2025).","journal-title":"Ann. Oncol."},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.annonc.2024.12.002","volume":"36","author":"L Zhou","year":"2025","unstructured":"Zhou, L. et al. Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib\/II dose-escalation and dose-expansion study. Ann. Oncol. 36, 331\u2013339 (2025).","journal-title":"Ann. Oncol."},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1158\/1078-0432.CCR-25-0419","volume":"31","author":"CF Stockem","year":"2025","unstructured":"Stockem, C. F. et al. Biomarker analysis and treatment dynamics following preoperative ipilimumab plus nivolumab in locally advanced urothelial cancer from the Phase IB NABUCCO Study. Clin. Cancer Res. 31, 3897\u20133906 (2025).","journal-title":"Clin. Cancer Res."},{"key":"1443_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccell.2019.11.006","volume":"36","author":"M Yarmarkovich","year":"2019","unstructured":"Yarmarkovich, M. & Maris, J. M. When cold is hot: immune checkpoint inhibition therapy for rhabdoid tumors. Cancer Cell 36, 575\u2013576 (2019).","journal-title":"Cancer Cell"},{"key":"1443_CR17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960\u20131964 (2006).","journal-title":"Science"},{"key":"1443_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1084887","volume":"14","author":"A Tiwari","year":"2023","unstructured":"Tiwari, A. et al. Towards a consensus definition of immune exclusion in cancer. Front. Immunol. 14, 1084887 (2023).","journal-title":"Front. Immunol."},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211.e10 (2019).","journal-title":"Immunity"},{"key":"1443_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","volume":"39","author":"M Hornburg","year":"2021","unstructured":"Hornburg, M. et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell 39, 928\u201344.e6 (2021).","journal-title":"Cancer Cell"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/modpathol.2016.109","volume":"29","author":"C Denkert","year":"2016","unstructured":"Denkert, C. et al. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Mod. Pathol. 29, 1155\u20131164 (2016).","journal-title":"Mod. Pathol."},{"key":"1443_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-020-0154-2","volume":"6","author":"M Amgad","year":"2020","unstructured":"Amgad, M. et al. Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group. npj Breast Cancer 6, 16 (2020).","journal-title":"npj Breast Cancer"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","volume":"30","author":"E Vorontsov","year":"2024","unstructured":"Vorontsov, E. et al. A foundation model for clinical-grade computational pathology and rare cancers detection. Nat. Med. 30, 2924\u20132935 (2024).","journal-title":"Nat. Med."},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41374-020-00514-0","volume":"101","author":"M Cui","year":"2021","unstructured":"Cui, M. & Zhang, D. Y. Artificial intelligence and computational pathology. Lab. Investig. 101, 412\u2013422 (2021).","journal-title":"Lab. Investig."},{"key":"1443_CR25","doi-asserted-by":"crossref","unstructured":"Zheng, Q. et al. Quantitative assessment of tumor-infiltrating lymphocytes using machine learning predicts survival in muscle-invasive bladder cancer. J. Clin. Med. 11, 7081 (2022).","DOI":"10.3390\/jcm11237081"},{"key":"1443_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2019.101563","volume":"58","author":"S Graham","year":"2019","unstructured":"Graham, S. et al. Hover-Net: simultaneous segmentation and classification of nuclei in multi-tissue histology images. Med. Image Anal. 58, 101563 (2019).","journal-title":"Med. Image Anal."},{"key":"1443_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101536","volume":"5","author":"R Gao","year":"2024","unstructured":"Gao, R. et al. Harnessing TME depicted by histological images to improve cancer prognosis through a deep learning system. Cell Rep. Med. 5, 101536 (2024).","journal-title":"Cell Rep. Med."},{"key":"1443_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2023.102936","volume":"90","author":"SF Abbas","year":"2023","unstructured":"Abbas, S. F., Vuong, T. T. L., Kim, K., Song, B. & Kwak, J. T. Multi-cell type and multi-level graph aggregation network for cancer grading in pathology images. Med. Image Anal. 90, 102936 (2023).","journal-title":"Med. Image Anal."},{"key":"1443_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2021.102264","volume":"75","author":"P Pati","year":"2022","unstructured":"Pati, P. et al. Hierarchical graph representations in digital pathology. Med. Image Anal. 75, 102264 (2022).","journal-title":"Med. Image Anal."},{"key":"1443_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31771-w","volume":"13","author":"L Qiu","year":"2022","unstructured":"Qiu, L. et al. Intratumor graph neural network recovers hidden prognostic value of multi-biomarker spatial heterogeneity. Nat. Commun. 13, 4250 (2022).","journal-title":"Nat. Commun."},{"key":"1443_CR31","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1016\/S2589-7500(22)00168-6","volume":"4","author":"K Ding","year":"2022","unstructured":"Ding, K., Zhou, M., Wang, H., Zhang, S. & Metaxas, D. N. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study. Lancet Digit. Health 4, e787\u2013e795 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"e0328816","DOI":"10.1371\/journal.pone.0328816","volume":"20","author":"C Hu","year":"2025","unstructured":"Hu, C. et al. Deep learning-based spatial analysis on tumor and immune cells of pathology images predicts MIBC prognosis. PLoS ONE 20, e0328816 (2025).","journal-title":"PLoS ONE"},{"key":"1443_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218059","volume":"634","author":"K Hammouda","year":"2025","unstructured":"Hammouda, K. et al. AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma. Cancer Lett. 634, 218059 (2025).","journal-title":"Cancer Lett."},{"key":"1443_CR34","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1200\/JCO.2025.43.16_suppl.3017","volume":"43","author":"E Ramberger","year":"2025","unstructured":"Ramberger, E. et al. Enhancing prognostic precision in bladder cancer: AI-driven tumor microenvironment analysis from H&E images. J. Clin. Oncol. 43, 3017 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1443_CR35","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1200\/JCO.21.02010","volume":"40","author":"S Park","year":"2022","unstructured":"Park, S. et al. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as complementary biomarker for immune checkpoint inhibition in non-small-cell lung cancer. J. Clin. Oncol. 40, 1916\u20131928 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1443_CR36","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s41374-021-00653-y","volume":"101","author":"Sobottka","year":"2021","unstructured":"Sobottka et al. Establishing standardized immune phenotyping of metastatic melanoma by digital pathology. Lab. Investig. 101, 1561\u20131570 (2021).","journal-title":"Lab. Investig."},{"key":"1443_CR37","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.ajpath.2024.02.016","volume":"194","author":"K Hamada","year":"2024","unstructured":"Hamada, K. et al. A deep learning-based assessment pipeline for intraepithelial and stromal tumor-infiltrating lymphocytes in high-grade serous ovarian carcinoma. Am. J. Pathol. 194, 1272\u20131284 (2024).","journal-title":"Am. J. Pathol."},{"key":"1443_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"1443_CR39","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378 (2024).","journal-title":"BMJ"},{"key":"1443_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40271-4","volume":"14","author":"R Arora","year":"2023","unstructured":"Arora, R. et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat. Commun. 14, 5029 (2023).","journal-title":"Nat. Commun."},{"key":"1443_CR41","doi-asserted-by":"publisher","first-page":"12258","DOI":"10.1073\/pnas.94.23.12258","volume":"94","author":"K Francis","year":"1997","unstructured":"Francis, K. & Palsson, B. O. Effective intercellular communication distances are determined by the relative time constants for cyto\/chemokine secretion and diffusion. Proc. Natl. Acad. Sci. USA 94, 12258\u201312262 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1443_CR42","doi-asserted-by":"crossref","unstructured":"Wang, J., Chen, R. J., Lu, M. Y., Baras, A. & Mahmood, F. (eds). Weakly supervised prostate TMA classification via graph convolutional networks. In Proc. 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI) (IEEE, 2020).","DOI":"10.1109\/ISBI45749.2020.9098534"},{"key":"1443_CR43","doi-asserted-by":"publisher","unstructured":"Zhou, Y. et al. Cgc-net: Cell graph convolutional network for grading of colorectal cancer histology images. In Proc. IEEE\/CVF International Conference on Computer Vision Workshops (pp. 0-0). https:\/\/doi.org\/10.48550\/arXiv.1909.01068 (2019).","DOI":"10.48550\/arXiv.1909.01068"},{"key":"1443_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41747-024-00428-2","volume":"8","author":"F Prinzi","year":"2024","unstructured":"Prinzi, F., Currieri, T., Gaglio, S. & Vitabile, S. Shallow and deep learning classifiers in medical image analysis. Eur. Radiol. Exp. 8, 26 (2024).","journal-title":"Eur. Radiol. Exp."},{"key":"1443_CR45","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. (eds). XGBoost: a scalable tree boosting system. In Proc. 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (Association for Computing Machinery, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"1443_CR46","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1021\/acs.jcim.6b00591","volume":"56","author":"RP Sheridan","year":"2016","unstructured":"Sheridan, R. P., Wang, W. M., Liaw, A., Ma, J. & Gifford, E. M. Extreme gradient boosting as a method for quantitative structure-activity relationships. J. Chem. Inf. Model. 56, 2353\u20132360 (2016).","journal-title":"J. Chem. Inf. Model."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01443-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:03:47Z","timestamp":1782471827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01443-9","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}